Salem, MA, United States of America

Joseph Chin


Average Co-Inventor Count = 13.3

ph-index = 5

Forward Citations = 247(Granted Patents)


Company Filing History:


Years Active: 1998-2007

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Joseph Chin: Innovator in Amyloid Modulation and Pharmaceutical Advancements

Introduction

Joseph Chin, based in Salem, MA, is a distinguished inventor with a notable portfolio of 6 patents. His pioneering work primarily revolves around the modulation of amyloid peptide aggregation, a significant field within biomedical research. His contributions are essential in understanding and treating various amyloidogenic diseases.

Latest Patents

Among his latest patents, Chin has developed compounds that modulate natural β-amyloid peptide aggregation, specifically those composed entirely of D-amino acids. These modulators include peptides based on β-amyloid peptides, typically containing 3 to 5 D-amino acid residues, including D-leucine, D-phenylalanine, and D-valine. A particularly notable embodiment of his invention is a retro-inverso isomer of a β-amyloid peptide. The advancements feature modifications at both the amino-terminus and the carboxy-terminus, employing various chemical groups to enhance their efficacy. Furthermore, Chin's patents encompass pharmaceutical compositions derived from these compounds and diagnostic methods aimed at amyloidogenic diseases.

Career Highlights

Joseph Chin works with Praecis Pharmaceuticals, Inc., where he continues to drive innovation in pharmaceutical development. His extensive body of work demonstrates a commitment to improving therapeutic outcomes through scientific innovation. With his six patents, Chin has established himself as an influential figure in the realm of biochemistry and therapeutics.

Collaborations

Throughout his career, Joseph has collaborated with notable colleagues, including Mark A. Findeis and Malcolm L. Gefter. These partnerships have fostered a synergistic environment, pushing the boundaries of research and development within the pharmaceutical landscape.

Conclusion

In summary, Joseph Chin's contributions in the field of amyloid modulation and his innovative patents underscore his role as a leading inventor in modern pharmaceutical science. His work not only offers prospects for treating amyloid-associated disorders but also reflects the collaborative spirit evident within the scientific community. His endeavors at Praecis Pharmaceuticals, Inc. are paving the way for future advancements in this crucial area of health research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…